Neonatal Vitamin D status and risk of multiple sclerosis: A population-based case-control study

Neurology

Volumn 88, Issue 1, 2017, Pages 44-51

  Nielsen, Nete Munk ^a   Munger, Kassandra L ^b   Koch Henriksen, Nils ^c,h   Hougaard, David M ^a   Magyari, Melinda ^c,d   Jørgensen, Kristian T ^a   Lundqvist, Marika ^a   Simonsen, Jacob ^a   Jess, Tine ^a   Cohen, Arieh ^a   Stenager, Egon ^c,e,f,g   Ascherio, Alberto ^b,i  

^a STATENS SERUM INSTITUT   (Denmark)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g MS Clinic of Southern Jutland (Sønderborg Vejle Esbjerg)   (Denmark)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIFEDIOL; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRIED BLOOD SPOT TESTING; ETHNICITY; FEMALE; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEWBORN; NEWBORN SCREENING; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; DENMARK; HEALTH CARE PLANNING; MULTIVARIATE ANALYSIS; ODDS RATIO; PARENT; VITAMIN D DEFICIENCY;

ADULT; CASE-CONTROL STUDIES; COMMUNITY HEALTH PLANNING; DENMARK; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; ODDS RATIO; PARENTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85007029640     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003454     Document Type: Article

References (39)

1. Word Health Organization. Neurological Disorders: Public Health Challenges. Geneva: Word Health Organization; 2006:85-95.
2. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520-532.
3. Salzer J, Hallmans G, Nystrom M, Stenlund H, Wadell G, Sundstrom P. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012;79:2140-2145.
4. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-2838.
5. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-65.
6. Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, Ascherio A. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol 2011;258:479-485.
7. Mokry LE, Ross S, Ahmad OS, et al. Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med 2015;12:e1001866.
8. Bayes HK, Weir CJ, O'Leary C. Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol 2010;63:36-40.
9. Grytten N, Torkildsen O, Aarseth JH, et al. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler 2013;19:1028-1034.
10. Torkildsen O, Grytten N, Aarseth J, Myhr KM, Kampman MT. Month of birth as a risk factor for multiple sclerosis: an update. Acta Neurol Scand Suppl 2012:58-62.
11. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005; 330:120.
12. Templer DI, Trent NH, Spencer DA, et al. Season of birth in multiple sclerosis. Acta Neurol Scand 1992;85: 107-109.
13. Eyles DW, Morley R, Anderson C, et al. The utility of neonatal dried blood spots for the assessment of neonatal vitamin D status. Paediatr Perinat Epidemiol 2010;24: 303-308.
14. Mirzaei F, Michels KB, Munger K, et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 2011;70:30-40.
15. Ueda P, Rafatnia F, Baarnhielm M, et al. Neonatal vitamin D status and risk of multiple sclerosis. Ann Neurol 2014;76:338-346.
16. Ascherio A, Munger KL. Not too late to take vitamin D supplements. Ann Neurol 2014;76:321-322.
17. Munger KL, Aivo J, Hongell K, Soilu-Hanninen M, Surcel HM, Ascherio A. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish Maternity Cohort. JAMA Neurol 2016;73:515-519.
18. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. The Danish Multiple Sclerosis Registry. Scand J Public Health 2011;39:62-64.
19. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull 2006;53:441-449.
20. Norgaard-Pedersen B, Hougaard DM. Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis 2007;30:530-536.
21. McGrath JJ, Eyles DW, Pedersen CB, et al. Neonatal vitamin D status and risk of schizophrenia: a populationbased case-control study. Arch Gen Psychiatry 2010;67: 889-894.
22. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
23. Eyles D, Anderson C, Ko P, et al. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta 2009;403:145-151.
24. Sablok A, Batra A, Thariani K, et al. Supplementation of vitamin D in pregnancy and its correlation with fetomaternal outcome. Clin Endocrinol 2015;83:536-541.
25. Vinkhuyzen AA, Eyles DW, Burne TH, et al. Prevalence and predictors of vitamin D deficiency based on maternal mid-gestation and neonatal cord bloods: the Generation R Study. J Steroid Biochem Mol Biol Epub 2015 Sep 15.
26. Gardener H, Munger KL, Chitnis T, Michels KB, Spiegelman D, Ascherio A. Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology 2009;20:611-618.
27. Montgomery SM, Lambe M, Olsson T, Ekbom A. Parental age, family size, and risk of multiple sclerosis. Epidemiology 2004;15:717-723.
28. Mueller BA, Nelson JL, Newcomb PA. Intrauterine environment and multiple sclerosis: a population-based casecontrol study. Mult Scler 2013;19:106-111.
29. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998;45:320-323.
30. Lucas RM, Ponsonby AL, Dear K, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011;76:540-548.
31. Mesliniene S, Ramrattan L, Giddings S, Sheikh-Ali M. Role of vitamin D in the onset, progression, and severity of multiple sclerosis. Endocr Pract 2013;19:129-136.
32. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599-612.
33. Absoud M, Cummins C, Lim MJ, Wassmer E, Shaw N. Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study. PLoS One 2011;6:e22179.
34. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180-188.
35. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 2013;45:217-226.
36. Wrzosek M, Lukaszkiewicz J, Wrzosek M, et al. Vitamin D and the central nervous system. Pharmacol Rep 2013; 65:271-278.
37. Eyles D, Almeras L, Benech P, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 2007;103: 538-545.
38. Almeras L, Eyles D, Benech P, et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 2007;7:769-780.
39. Saraf R, Morton SM, Camargo CA Jr, Grant CC. Global summary of maternal and newborn vitamin D status: a systematic review. Matern Child Nutr 2016;12:647-668.